Biologic therapies and psychobiome traits in inflammatory bowel diseases

被引：0
|
作者：
Tavakoli, P. [1 ]
Vollmer-Conna, U. [2 ]
Hadzi-Pavlovic, D. [2 ]
Vazquez-Campos, X. [3 ]
Grimm, M. C. [1 ]
机构：
[1] Univ New South Wales, St George & Sutherland Clin Sch, Fac Med, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia
[3] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
28
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [31] Discussion: DMARDs and biologic therapies in the management of inflammatory joint diseases
    Vaz, Austin
    Lisse, Jeffrey
    Rizzo, Warren
    Albani, Salvatore
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (03) : 291 - 299
  • [32] Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies
    Qian Cai
    Zhijie Ding
    Alex Z. Fu
    Aarti A. Patel
    BMC Gastroenterology, 22
  • [33] Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies
    Cai, Qian
    Ding, Zhijie
    Fu, Alex Z.
    Patel, Aarti A.
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [34] CMV Reactivation Is Rare in the Era of Biologic Therapies for Inflammatory Bowel Disease
    Hissong, Erika
    Yantiss, Rhonda
    MODERN PATHOLOGY, 2018, 31 : 269 - 269
  • [35] CMV Reactivation Is Rare in the Era of Biologic Therapies for Inflammatory Bowel Disease
    Hissong, Erika
    Yantiss, Rhonda
    LABORATORY INVESTIGATION, 2018, 98 : 269 - 269
  • [36] Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
    Baumgart, Daniel C.
    Le Berre, Catherine
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1302 - 1315
  • [37] Market share and costs of biologic therapies for inflammatory bowel disease in the USA
    Yu, H.
    MacIsaac, D.
    Wong, J. J.
    Sellers, Z. M.
    Wren, A. A.
    Bensen, R.
    Kin, C.
    Park, K. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (03) : 364 - 370
  • [38] Biological therapies and biomicrobial dynamics in inflammatory bowel diseases
    Tavakoli, P.
    Vollmer-Conna, U.
    Hadzi-Pavlovic, D.
    Campos, X. Vazquez
    Grimm, M. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 86 - 87
  • [39] Mechanisms and Efficacy of Immunobiologic Therapies for Inflammatory Bowel Diseases
    Ghosh, Nilanjan
    Chaki, Rituparna
    Mandal, Vivekananda
    Lin, G. David
    Mandal, Subhash C.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2010, 29 (01) : 4 - 37
  • [40] Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases
    Trivedi, Itishree
    Hanauer, Stephen B.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1915 - 1934
12345